Full details of the University of Oxford and AstraZeneca vaccine trial, led in Scotland by the University of Glasgow and NHSGGC, has been published in the medical journal, the Lancet. This includes results of the two different dose regimes. The University's trial leads, Prof Andrew Smith and Prof Emma Thomson would like to thank the many University and NHS staff who took part and continue to support the trial.

Prof Andrew Smith said: “With the publication of the Oxford/AZ vaccine trial interim results, it seems like a good time to reflect on the process in Glasgow. The paradox is that back at the end of April when colleagues in Oxford first got in touch to enquire if Glasgow would participate as a vaccine trial site it seems like such a short time ago; on the other hand it feels so much longer and so much has happened.

“What we have found particularly striking is the extent of teamwork involved, especially from the study participants perspective. We know that at times it has not always been easy with the flow of information and the media spotlight. The teamwork from the NHS Clinical Research Facility has been remarkable, including study co-ordinators, pharmacists and medical staff. The volunteering from medical staff on top of clinical duties, providing an on-call service for participants, has been especially impressive, and we want to give our thanks to everyone involved from UofG from all sides.

“Transparency in publication and communication is especially important in clinical trials and this interim analysis from the Oxford group is vital in this respect.”

First published: 14 December 2020

<< 14 December 2020


Full details published in the Lancet